Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Tweetable abstract Successful translation of regenerative medicine projects to the clinic requires attention to the complex interaction of spatial and timing issues from manufacturing to clinical use.

Original publication

DOI

10.2217/rme-2020-0164

Type

Journal article

Journal

Regen Med

Publication Date

24/02/2021

Keywords

cell manufacturing, clinical integration, infrastructure, institutional readiness, space, timing